एवानाफिल और वेरिसिगुआट का इंटरैक्शन

• Administration with guanylate cyclase (GC) stimulators such as riociguat and vericiguat ( 4.3 )

Concomitant Guanylate Cyclase (GC) Stimulators Do not use avanafil tablets in patients who are using a GC stimulator, such as riociguat or vericiguat.

When vasodilators are used in combination, an additive effect on blood pressure may be anticipated.

When vasodilators are taken in combination, blood-pressure-lowering effects of each individual compound may be increased.

When vasodilators are taken in combination, blood pressure-lowering effects of each individual compound may be increased.

PDE-5 Inhibitors: Concomitant use is not recommended.

PDE-5 Inhibitors Concomitant use of VERQUVO with PDE-5 inhibitors is not recommended because of the potential for hypotension [see Clinical Pharmacology (12.2) ] .